retatrutide clinical use UK 2026: Phase 3 Results Retatrutide Subcutaneous Fat Loss Results:

7 A meta-analysis of outcomes data from completed cardiovascular outcome trials suggests that, apart from saxagliptin, DPP-4 inhibitors have a neutral effect on the risk of cardiovascular death, myocardial infarction, stroke and hospitalisation for heart failure

Wegovy Showed the Strongest Signal Although Ozempic generated far more reports overall because it was approved earlier, Wegovy showed the strongest association with ION

This may involve starting at a lower dose and gradually increasing it, especially if you previously experienced side effects

While clotting factor replacement therapies are usually given by infusion or injection, people with hemophilia may also take other medications that could be affected

Marfella R, Prattichizzo F, Sardu C, et al